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Synthetic procedures
Compound 1:
POCl 3 (2.5 mL, 26 mmol) and trimethylamine (7.3 mL, 52 mmol) were dissolved in 100 mL dry THF and cooled to 0 °C. Dioxetane 1d [1] (800 mg, 2.6 mmol) was added dropwise over 60 minutes and the solution stirred at 0 °C for 60 minutes. After completion, the reaction mixture diluted with 10% NaOH (30 ml) and stirred for 30 min before quench with sat. NH 4 Cl. The mixture diluted with EtOAc and the organic layer was separated, washed with brine, dried over Na 2 SO 4 and evaporated under reduced pressure. The crude product was purified by preparative RP-HPLC to give compound 1 (681 mg, 63% yield).
1 H NMR (400 MHz, D 2 O) δ 7.27-7.16 (m, 2H), 7.03 (d, J = 22.1 Hz, 1H), 3.22 (s, 3H), 2.99 (s, 1H), 1.96 (s, 1H), 1.69-1.37 (m, 12H).; 13 C-NMR (100 MHz, D 2 O) δ 156. 96, 156.76, 138.84, 138.14, 133.42, 129.82, 129.82, 126.48, 121.93, 121.41, 117.14, 117.14, 115.17, 101.16, 100.77, 76.66, 74.80, 73.26, 71.81, 70.47, 62.26, 60.69, 38.66, 38.66, 38.66, 38.66, 37.93, 33.40, 33.40, 28.20, 28.20.; 
MeOH
Compound 2c:
Enol ether 1a [1] (100 mg, 0.33 mmol) was dissolved in 5 mL dry DMF and cooled to 0 °C. K 2 CO 3 (68 mg, 0.5 mmol) was added and the solution stirred at 0 °C for 10 minutes, before iodide 1b [1] (372 mg, 0.66 mmol) was added. The reaction mixture stirred for 60 minutes at room temperature and monitored by TLC. After completion, the reaction mixture diluted with MeOH (10 ml) and stirred for 30 min before quench with sat. NH 4 Cl. The mixture diluted with EtOAc and the organic layer was separated, washed with brine, dried over Na 2 SO 4 and evaporated under reduced pressure. The crude product was purified by silica gel column chromatography to afford the corresponding product 2c (149 mg, 79% yield). 80 -3.70 (m, 2H), 3.60 -3.49 (m, 7H), 3.32 -3.20 (m, 5H) , 2.09 -1.67 (m, 13H). 13 C-NMR (100 MHz, CDCl 3 ) δ 170. 40, 170.29, 170.16, 169.45, 167.91, 156.78, 155.84, 141.49, 139.50, 137.45, 133.77, 133.35, 131.20, 129.34, 128.88, 123.52, 118.62, 117.07, 115.42, 99.1, 71.05, 70.84, 70.02, 68.63, 66.87, 63.38, 61.34, 57.61, 51.65, 39.21, 37.02, 32.58, 30.20, 28.17, 20.76, 20.68, 20.61 96, 156.76, 138.84, 138.14, 133.42, 129.82, 129.82, 126.48, 121.93, 121.41, 117.14, 117.14, 115.17, 101.16, 100.77, 76.66, 74.80, 73.26, 71.81, 70.47, 62.26, 60.69, 38.66, 38.66, 38.66, 38.66, 37.93, 33.40, 33.40, 28.20, 28.20 Enol ether 1a (100 mg, 0.33 mmol) was dissolved in 5 mL dry DMF and cooled to 0 °C. K 2 CO 3 (68 mg, 0.5 mmol) was added and the solution stirred at 0 °C for 10 minutes, before iodide 1b (231 mg, 0.66 mmol) was added. The reaction mixture stirred for 60 minutes at S7 room temperature and monitored by TLC. After completion, the reaction mixture diluted with EtOAc and the organic layer was separated, washed with brine, dried over Na 2 SO 4 and evaporated under reduced pressure. The crude product and catalytic amount of methylene blue were dissolved in 20 ml of DCM. Oxygen was bubbled through the solution while irradiating with yellow light. The reaction was monitored by RP-HPLC. After completion, the reaction mixture was concentrated by evaporation under reduced pressure. 157.52, 139.22, 138.07, 134.78, 132.64, 129.45, 129.45, 129.18, 129.18, 128.42, 128.27, 128.27, 126.78, 126.56, 122.54, 120.77, 120.77, 117.86, 114.97, 91.94, 71.43, 52.09, 43.43, 37.93, 34.88, 34.88, C 33 H 34 ClNO 5 Na [M + Na] + 582.7, found 583.1. Enol ether 1f (100 mg, 0.37 mmol) was dissolved in 5 mL dry DMF and cooled to 0 °C. 141.01, 139.27, 133.05, 133.05, 127.48, 127.10, 127.10, 121.37, 121.07, 120.83, 117.98, 116.30, 92.60, 87.49, 87.49, 70.84, 52.09, 37.93, 34.88, 34.88, 33.62, 33.62, 33.62, 33.62, 30.31, 30.31, 24.70, 24.70, 24.70, 24.70 Compound 5:
Enol ether 1a (100 mg, 0.33 mmol) was dissolved in 5 mL dry DMF and cooled to 0 °C. (s, 12H); 13 C-NMR (100 MHz, CDCl 3 ) δ 170. 40, 170.29, 170.16, 169.45, 167.91, 156.78, 155.84, 141.49, 139.50, 137.45, 133.77, 133.35, 131.20, 129.34, 128.88, 123.52, 118.62, 117.07, 115.42, 99.1, 71.05, 70.84, 70.02, 68.63, 66.87, 63.38, 61.34, 57.61, 51.65, 39.21, 37.02, 32.58, 30.20, 28.17, 20.76, 20.68, 20.61 
Quintative
MCD-A TMCD-FITC
TMCD-FITC:
FITC (66 mg, 0.17 mmol) was added to a solution of MCD-A (200 mg, 0.14 mmol) in 3 mL DMF and stirred for 10h. After completion, the mixture diluted with water and purified by preparative RP-HPLC (gradient of ACN in water) to give TMCD-FITC (250 mg, 100% S10 yield 177.96, 168.69, 160.67, 156.02, 149.20, 146.47, 132.09, 130.90, 128.49, 127.62, 127.22, 125.06, 124.37, 121.37, 118.61, 118.12, 117.63, 110.93, 104.33, 103.09, 100.71, 100.71, 100.71, 100.71, 100.71, 100.71, 100.71, 83.71, 83.71, 83.71, 83.71, 83.71, 83.71, 83.71, 82.94, 82.94, 82.94, 82.94, 82.94, 82.94, 82.94, 79.03, 75.73, 75.73, 75.73, 75.73, 75.73, 75.73, 74.24, 72.43, 72.43, 72.43, 72.43, 72.43, 72.43, 71.82, 71.82, 71.82, 71.82, 71.82, 71.82, 58.84, 58.84, 58.84, 58.84, 58.84, 58.84, 58.84, 58.84, 58.84, 58.84, 58.84, 58.84, 58.84, 58.84, 58.70, 58.70, 58.70, 58.70, 58.70, 58.70, 44.35 
Quintative 
MCD-A TMCD-Cy5
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Proposed chemiluminescence enhancement mechanism
To better understand the enhancement mechanism of the TMCD with Schaap's 1,2-dioxetane, we have examined the fluorescence enhancement exhibited for the emitter (benzoate) and TMCD. The direct chemiluminescence generated by emission of the corresponding dioxetane probe in water is directly affected from the fluorescence efficiency of the benzoate ester. As presented in Figure S10 , the fluorescence of 3-hydroxybenozte (3-HB) was significantly higher after incubation with TMCD compared to that of the control experiment. The complexation with TMCD improved the fluorescence intense signal of 3-HB with almost 13-folds. This result supports our proposed CL enhancement mechanism using supramolecular enhancer adducts. The chemiluminescence probe is encapsulated with TMCD to form a stable inclusion, then, activation of the probe led to the generation of the excited benzoate to emit an enhanced chemiluminescent light. 
Correlation between TMCD and TMCD-FITC Chemiluminescence Enhancement
In order to examine the complexation effect of TMCD-FITC compared to that of TMCD,
we have plotted the relative chemiluminescence enhancement of TMCD-FITC as a S17 function of the relative enhancement achieved with TMCD for each probe (1-4). As shown in Figure S11 , an excellent linear correlation was obtained with R 2 of 0.975. This result means that the complexation effect and strength of the CD derivatives is similar with probes 1-4. Therefore the only difference is the energy transfer achieved with the TMCD-FITC, which leads to further 30-folds higher light emission. Figure S11 : Correlation between the relative chemiluminescence enhancement using TMCD and TMCD-FITC with probes 1-4.
The equilibrium constant calculation: Christoph Ruediger Bauer (ETH, Zurich). All cell lines were cultured in DMEM growing media supplemented with 10% FBS, 100 μg/mL streptomycin, 100 units/mL penicillin, 12.5 units/mL nystatin and 2 mM L-glutamine. Cells were grown at 37°C; 5% CO 2 .
Cell viability experiment
The assay was performed as previously reported in Gnaim, S. et al, Angew. Chem. Int. 
Protocol of chemiluminescence microscopy imaging of β-galactosidase activity
Chemiluminescence images were acquired using Olympus LV200 inverted microscope fitted with an EMCCD camera (Hamamatsu C9100-13 
Ethics Statement
All animal procedures were performed in compliance with Tel Aviv University, Sackler
School of Medicine guidelines and protocols approved by the Institutional Animal Care and Use Committee.
Intravital non-invasive chemiluminescence imaging of probe 5 activation in mice
To induce acute inflammation, 1 mL (0.1 mg/mL) of LPS (Lipopolysaccharides from Escherichia coli 055:B5, Sigma) was injected into the peritoneal cavity (i.p.) of Balb/c mice. A second control group of mice was injected i.p. with 1 mL of PBS. Four hours later, both mice groups were additionally injected i.p. with 100 µL of 100 µM of probe 5 or100 µL of 100 µM of probe 5 and 300 μM of TMCD-Cy5. Twenty minutes later, mice were anesthetized using ketamine (100 mg/kg) and xylazine (12 mg/kg), and imaged by
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BioSpace Lab PhotonIMAGER TM . Activated probe 5 chemiluminescence signal was quantified as total signal of photons/exposure time (sec). Data is expressed as mean ± S.D.
P-NMR titration study
To determine the complexation constant of TMCD with probe 1, titration experiment was carried out directly in an NMR tube. The kinetic of the complexation reaction was studied by 31 P-NMR spectroscopy. Typical procedure: 5 mg of the appropriate probe 1 was dissolved in 1000 µL D 2 O. The latter solution was divided to two 500 µL solutions, A and B. Solution A was transferred to an NMR tube, and to solution B was added 50 mg of TMCD. The spectra were measured after the addition of various amounts of solution B (17, 33, 65, 129, 257 , 500 µL) to solution A.
H-NMR crystallization experiment
The crystallization experiment was carried out by typical crystallization protocol. 960 mg of TMCD was dissolved in 950 µL of water and 50 µL of DMF, then 80 mg probe 2 was
